Carl Icahn Involvement with Vivus (VVUS) Seen as 'Very Significant Positive'
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/23/2026
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- UBS says bull market has further to run
- S&P 500 may pull back before midterms, but Citi says buy the dip
- Global yield relief evaporates as U.S. rates push back toward multi-decade peaks
- BofA's Hartnett sees dollar slump, risk selloff if bond intervention fails
- Applied Optoelectronics sets up $600M at-the-market stock offering
- Fannie Mae loses at least 10 senior executives amid departures - WSJ
- Wall St rises on the day but falls for the week; bond yields and Iran in focus
- Morgan Stanley course-corrects their semiconductor equipment outlook on demand
- One killed, three injured when man attacks Swedish school with sword
VIVUS (VVUS) Shorts Squeezed
September 11, 2015 9:46 AM EDTVIVUS (NASDAQ: VVUS) shorts were squeezed Friday as shares continued to advance on news Carl Icahn is involved in the name.
Earlier this week, Icahn offered to tender VIVUS convertible senior notes. Many including analysts at RBC saw reports of the activist investor's... More
VIVUS (VVUS) Adds to Recent Gains
September 11, 2015 9:33 AM EDTVIVUS (NASDAQ: VVUS) shares started off strong Friday. The stock is up around 7 percent following a 15 percent move higher on yesterday's session.
On Wedneday, it was... More
VIVUS (VVUS) Ticks Higher in Late Trading
September 10, 2015 4:47 PM EDTVIVUS (NASDAQ: VVUS) shares are active in post-market trading. The stock is indicated over 3 percent higher.
On Wedneday, it was... More
Hedge Funds Skim the Bottom in Weightloss Dogs (VVUS) (OREX) (ARNA)
September 10, 2015 9:49 AM EDTSpeculators are getting excited again about beaten-to-the-ground weight-loss drug stocks - Orexigen Therapeutics (NASDAQ: OREX), VIVUS (NASDAQ: VVUS) and Arena Pharma (NASDAQ: ARNA) - following... More
Icahn Enterprises (IEP) Offers to Buy VIVUS (VVUS) Convertible Senior Notes
September 9, 2015 9:43 AM EDTIEH Biopharma LLC, a subsidiary of Icahn Enterprises L.P. (NASDAQ: IEP), today announced a cash tender offer for any and all of the outstanding 4.50% Convertible Senior Notes due 2020 of VIVUS, Inc. (Nasdaq: VVUS) at a price of $680 for each $1,000 of principal amount of Notes validly tendered and not validly withdrawn, plus accrued but unpaid interest from the last interest payment date up to, but excluding, the date of payment for the Notes by the Offeror.
The Offer will expire at 5:00 p.m., New York City time,... More
